Enteral Nutrition Market, By Product Type (Standard Enteral Nutrition and Enteral Nutrition for Chronic Illness), By Nutrition Type (Proteins, Carbohydrates, Multi-vitamins and Antioxidants, Amino Acid, Fibers, Minerals, and Others), By Formulation (Powde

Enteral Nutrition Market, By Product Type (Standard Enteral Nutrition and Enteral Nutrition for Chronic Illness), By Nutrition Type (Proteins, Carbohydrates, Multi-vitamins and Antioxidants, Amino Acid, Fibers, Minerals, and Others), By Formulation (Powder and Liquid), By Patient Type (Infant (1 month to 2 years), Children (2 to 12 years), Adolescent & Adult (12 to 65 years), Geriatric (>65 years), and Chronic Patient (Excluding all above in all age groups)), By Application (Cancer, Gastrointestinal Diseases, Diabetes, Critical Care, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-commerce), By End User (Hospitals, Home Care Settings, Retirement Homes, and Others), and By Region (North America, Latin America, Asia Pacific, and Europe, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Enteral nutrition refers to delivery of food containing carbohydrates, proteins, water, fat, minerals, and vitamins in the body using gastrointestinal tract with the help of feeding tubes. It is imperative for patients having functional gastrointestinal tract however are, unable to maintain a safe or adequate oral intake. Furthermore, a tube placed in nose, is known as nasoenteral tube, where it passes through the nasal cavity and into the stomach. However, when a tube passes through the skin into the stomach, it is called gastrostomy. Such tubes aid patients to ingest food, who are unable to consume normally.
Market Dynamics
Increasing incidence of chronic diseases such as cancer, diabetes, gastrointestinal disorder, and cardiovascular diseases, increasing novel product launch and approvals, and increasing adoption of growth strategies such as acquisition and collaboration by key players operating in the market are the important factors expected to drive the market growth over the forecast period. For instance, in September 2021, Nestlé Health Science in collaboration with StartSe and R&D manufacturing specialists launched ‘Nestle Beyond Food’, a nutrition-based health program. Through this program, Nestle selected Brazilian startup businesses it wished to work with based on their business execution, nutritional support for outpatient, nutritional product solutions, and e-Health technologies.
Moreover, in March 2017, B. Braun Medical Ltd., launched a new range of nutritionally complete dietary drinks - Nutricomp Drink Plus. It is available in four flavors; the high-energy milkshake style supplement can be prescribed for the dietary management of malnutrition and can also be administered by tube in critically weak patients.
Key features of the study:
This report provides in-depth analysis of the global enteral nutrition market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global enteral nutrition market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Abbott Laboratories, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., and Curtis Health Caps SP
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global enteral nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global enteral nutrition market
Detailed Segmentation:
Global Enteral Nutrition Market, By Product Type:
Standard Enteral Nutrition
Enteral Nutrition for Chronic Illness
Global Enteral Nutrition Market, By Nutrition Type:
Proteins
Carbohydrates
Multi-vitamins and Antioxidants
Amino Acid
Fibers
Minerals
Others
Global Enteral Nutrition Market, By Formulation:
Powder
Liquid
Global Enteral Nutrition Market, By Patient Type:
Infant (1 month to 2 years)
Children (2 to 12 years)
Adolescent & Adult (12 to 65 years)
Geriatric (>65 years)
Chronic Patient (Excluding all above in all age groups)
Global Enteral Nutrition Market, By Application:
Cancer
Gastrointestinal Diseases
Diabetes
Critical Care
Others
Global Enteral Nutrition Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
E-commerce
Global Enteral Nutrition Market, By End User:
Hospitals
Home Care Settings
Retirement Homes
Others (Nursing Care Centers, Rehabilitation Care Centers, etc.)
Global Enteral Nutrition Market, By Region:
North America
By Product Type
Standard Enteral Nutrition
Enteral Nutrition for Chronic Illness
By Nutrition Type
Proteins
Carbohydrates
Multi-vitamins and Antioxidants
Amino Acid
Fibers
Minerals
Others
By Formulation
Powder
Liquid
By Patient Type
Infant (1 month to 2 years)
Children (2 to 12 years)
Adolescent & Adult (12 to 65 years)
Geriatric (>65 years)
Chronic Patient (Excluding all above in all age groups)
By Application
Cancer
Gastrointestinal Diseases
Diabetes
Critical Care
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
E-commerce
By End User
Hospitals
Home Care Settings
Retirement Homes
Others (Nursing Care Centers, Rehabilitation Care Centers, etc.)
By Country
U.S.
Canada
Latin America
By Product Type
Standard Enteral Nutrition
Enteral Nutrition for Chronic Illness
By Nutrition Type
Proteins
Carbohydrates
Multi-vitamins and Antioxidants
Amino Acid
Fibers
Minerals
Others
By Formulation
Powder
Liquid
By Patient Type
Infant (1 month to 2 years)
Children (2 to 12 years)
Adolescent & Adult (12 to 65 years)
Geriatric (>65 years)
Chronic Patient (Excluding all above in all age groups)
By Application
Cancer
Gastrointestinal Diseases
Diabetes
Critical Care
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
E-commerce
By End User
Hospitals
Home Care Settings
Retirement Homes
Others (Nursing Care Centers, Rehabilitation Care Centers, etc.)
By Country
Brazil
Argentina
Mexico
Colombia
Peru
Rest of Latin America
Asia Pacific
By Product Type
Standard Enteral Nutrition
Enteral Nutrition for Chronic Illness
By Nutrition Type
Proteins
Carbohydrates
Multi-vitamins and Antioxidants
Amino Acid
Fibers
Minerals
Others
By Formulation
Powder
Liquid
By Patient Type
Infant (1 month to 2 years)
Children (2 to 12 years)
Adolescent & Adult (12 to 65 years)
Geriatric (>65 years)
Chronic Patient (Excluding all above in all age groups)
By Application
Cancer
Gastrointestinal Diseases
Diabetes
Critical Care
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
E-commerce
By End User
Hospitals
Home Care Settings
Retirement Homes
Others (Nursing Care Centers, Rehabilitation Care Centers, etc.)
By Country
Japan
China
South Korea
Vietnam
Philippines
India
Thailand
Indonesia
Malaysia
Australia
Taiwan
Rest of Asia Pacific
Europe, Middle East, and Africa
By Product Type
Standard Enteral Nutrition
Enteral Nutrition for Chronic Illness
By Nutrition Type
Proteins
Carbohydrates
Multi-vitamins and Antioxidants
Amino Acid
Fibers
Minerals
Others
By Formulation
Powder
Liquid
By Patient Type
Infant (1 month to 2 years)
Children (2 to 12 years)
Adolescent & Adult (12 to 65 years)
Geriatric (>65 years)
Chronic Patient (Excluding all above in all age groups)
By Application
Cancer
Gastrointestinal Diseases
Diabetes
Critical Care
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
E-commerce
By End User
Hospitals
Home Care Settings
Retirement Homes
Others (Nursing Care Centers, Rehabilitation Care Centers, etc.)
By Country
Germany
France
Italy
U.K.
Netherlands
Spain
Saudi Arabia
Russia
Egypt
South Africa
Turkey
Sweden
Rest of Europe, Middle East and Africa
Company Profiles
Abbott Laboratories*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Nestlé S.A.
Danone S.A.
Fresenius Kabi AG
Mead Johnson & Company, LLC
Braun Melsungen AG
Otsuka Pharmaceutical Co., Ltd
Meiji Holdings Co., Ltd.
Bahrain Pharma
Bionova Lifesciences
Global Health Products Inc.
Victus Inc.
Curtis Health Caps SP
“*” marked represents similar segmentation in other categories in the respective section.